Your browser doesn't support javascript.
loading
CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.
Chen, Luxi; Youssef, Youssef; Robinson, Cameron; Ernst, Gabrielle F; Carson, Mary Y; Young, Karen A; Scoville, Steven D; Zhang, Xiaoli; Harris, Regine; Sekhri, Palak; Mansour, Anthony G; Chan, Wing K; Nalin, Ansel P; Mao, Hsiaoyin C; Hughes, Tiffany; Mace, Emily M; Pan, Yinghong; Rustagi, Navin; Chatterjee, Sujash S; Gunaratne, Preethi H; Behbehani, Gregory K; Mundy-Bosse, Bethany L; Caligiuri, Michael A; Freud, Aharon G.
Affiliation
  • Chen L; Biomedical Sciences Graduate Program, Medical Scientist Training Program, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The
  • Youssef Y; Department of Pathology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Robinson C; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Ernst GF; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Carson MY; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Young KA; Department of Pathology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Scoville SD; Biomedical Sciences Graduate Program, Medical Scientist Training Program, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The
  • Zhang X; Center for Biostatistics, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Harris R; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Sekhri P; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Mansour AG; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Chan WK; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA; Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA
  • Nalin AP; Biomedical Sciences Graduate Program, Medical Scientist Training Program, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The
  • Mao HC; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Hughes T; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA.
  • Mace EM; Department of Pediatrics, Columbia University, New York, NY 10027 USA.
  • Pan Y; Department of Biology and Biochemistry, University of Houston, Houston, TX 77204 USA.
  • Rustagi N; Department of Biology and Biochemistry, University of Houston, Houston, TX 77204 USA.
  • Chatterjee SS; Department of Biology and Biochemistry, University of Houston, Houston, TX 77204 USA.
  • Gunaratne PH; Department of Biology and Biochemistry, University of Houston, Houston, TX 77204 USA.
  • Behbehani GK; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA; Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA
  • Mundy-Bosse BL; Division of Hematology, Department of Internal Medicine, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA; Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA
  • Caligiuri MA; City of Hope National Medical Center, Duarte, CA 91010 USA. Electronic address: mcaligiuri@coh.org.
  • Freud AG; Department of Pathology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA; Comprehensive Cancer Center, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH 43210 USA. Electronic address: aharon.fre
Immunity ; 49(3): 464-476.e4, 2018 09 18.
Article in En | MEDLINE | ID: mdl-30193847
ABSTRACT
According to the established model of murine innate lymphoid cell (ILC) development, helper ILCs develop separately from natural killer (NK) cells. However, it is unclear how helper ILCs and NK cells develop in humans. Here we elucidated key steps of NK cell, ILC2, and ILC3 development within human tonsils using ex vivo molecular and functional profiling and lineage differentiation assays. We demonstrated that while tonsillar NK cells, ILC2s, and ILC3s originated from a common CD34-CD117+ ILC precursor pool, final steps of ILC2 development deviated independently and became mutually exclusive from those of NK cells and ILC3s, whose developmental pathways overlapped. Moreover, we identified a CD34-CD117+ ILC precursor population that expressed CD56 and gave rise to NK cells and ILC3s but not to ILC2s. These data support a model of human ILC development distinct from the mouse, whereby human NK cells and ILC3s share a common developmental pathway separate from ILC2s.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palatine Tonsil / Killer Cells, Natural / Lymphocytes Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palatine Tonsil / Killer Cells, Natural / Lymphocytes Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Immunity Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Type: Article